NCBI Home Page NCBI Site Search page NCBI Guide that lists and describes the NCBI resources
Conserved domains on  [gi|56121818|ref|NP_076984|]
View 

probable dolichyl pyrophosphate Glc1Man9GlcNAc2 alpha-1,3-glucosyltransferase isoform a [Homo sapiens]

Protein Classification

ALG6/ALG8 family glucosyltransferase( domain architecture ID 10504452)

ALG6/ALG8 family glucosyltransferase adds glucose residues to lipid-linked oligosaccharide precursors for asparagine-linked glycosylation, such as dolichyl pyrophosphate Man9GlcNAc2 alpha-1,3-glucosyltransferase (ALG6) and dolichyl pyrophosphate Glc1Man9GlcNAc2 alpha-1,3-glucosyltransferase (ALG8); belongs to the glycosyltransferase family 57

CAZY:  GT57
EC:  2.4.1.-
Gene Ontology:  GO:0006488|GO:0006487|GO:0046527

Graphical summary

 Zoom to residue level

show extra options »

Show site features     Horizontal zoom: ×

List of domain hits

Name Accession Description Interval E-value
Alg6_Alg8 pfam03155
ALG6, ALG8 glycosyltransferase family; N-linked (asparagine-linked) glycosylation of proteins ...
21-510 0e+00

ALG6, ALG8 glycosyltransferase family; N-linked (asparagine-linked) glycosylation of proteins is mediated by a highly conserved pathway in eukaryotes, in which a lipid (dolichol phosphate)-linked oligosaccharide is assembled at the endoplasmic reticulum membrane prior to the transfer of the oligosaccharide moiety to the target asparagine residues. This oligosaccharide is composed of Glc(3)Man(9)GlcNAc(2). The addition of the three glucose residues is the final series of steps in the synthesis of the oligosaccharide precursor. Alg6 transfers the first glucose residue, and Alg8 transfers the second one. In the human alg6 gene, a C->T transition, which causes Ala333 to be replaced with Val, has been identified as the cause of a congenital disorder of glycosylation, designated as type Ic OMIM:603147.


:

Pssm-ID: 460831  Cd Length: 477  Bit Score: 589.08  E-value: 0e+00
                          10        20        30        40        50        60        70        80
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 56121818    21 VTLLKCLLIPTYHSTDFEVHRNWLAITHSLPISQWYYEATSEWTLDYPPFFAWFEYILSHVAKYF-DQEMLNVH-NLNYS 98
Cdd:pfam03155   1 ALLLKLLLPPMYHSTDFEVHRHWLEITHNLPISQWYFEDLSYWTLDYPPLFAYFEWLLGQIAPSFiDPEWVALHsSRGYE 80
                          90       100       110       120       130       140       150       160
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 56121818    99 SSRTLLFQRFSVIFMDVLFVY-AVRECCKCIDGKKVGKelteKPKFILSVLLLWNFGLLIVDHIHFQYNGFLFGLMLLSI 177
Cdd:pfam03155  81 SWSTKLFMRLTVIVSDLLLYIpALLLFIRKSLSGKSSK----RQQFIAALLILLSPGLLLIDHGHFQYNGFLLGLLLLSI 156
                         170       180       190       200       210       220       230       240
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 56121818   178 ARLFQKRHMEGAFLFAVLLHFKHIYLYVAPAYGVYLLRSYCFTAnkpdgsiRWKSFSFVRVISLGLVVFLVSALSLGPFL 257
Cdd:pfam03155 157 AALLKGRYLLGAILFALLLNFKHMYLYYAPAYFVYLLRKYCLNF-------PIRKFNFLRLLKLGLTVLATFALSFGPFL 229
                         250       260       270       280       290       300       310       320
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 56121818   258 ALNQLPQVFSRLFPFKRGLCHAYWAPNFWALYNALDKVLSVIGLKLKFLDpnnipkasmTSGLVQQFQHTVLPSVTPLAT 337
Cdd:pfam03155 230 YSGQLPQVLSRLFPFSRGLFHDYWAPNFWCLYNFLDKVLIVLAPRLGLLV---------TRGLVGDTSFAVLPQILPKLT 300
                         330       340       350       360       370       380       390       400
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 56121818   338 LICTLIAILPSIFCLWFKPQgPRGFLRCLTLCALSSFMFGWHVHEKAILLAILPMSLLSVGKAGDASIFLILTTTGHYSL 417
Cdd:pfam03155 301 LILTLLAQLPSLIKLFLRPS-KRLFLLALTLCSLSFFLFSWHVHEKAILLVLLPLSLLALEDPRDLSLFRWLSNVGTFSL 379
                         410       420       430       440       450       460       470       480
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 56121818   418 FPLLFTAPELPIKILLMLLFTIYSISSLKTLFRKEKP-----LFNWMETFYLLGLGPLEVCCEFVFPFTSWKVKYPFIPL 492
Cdd:pfam03155 380 FPLLFKDGLLLIKVVLTLLWNILFGLALRKLARLPFPslrvfLLDRLELLYLLSLIGMLVLHCLLHLLVPPPARYPFLPL 459
                         490
                  ....*....|....*...
gi 56121818   493 LLTSVYCAVGITYAWFKL 510
Cdd:pfam03155 460 MLTSVYCSFGVFYSFLLY 477
 
Name Accession Description Interval E-value
Alg6_Alg8 pfam03155
ALG6, ALG8 glycosyltransferase family; N-linked (asparagine-linked) glycosylation of proteins ...
21-510 0e+00

ALG6, ALG8 glycosyltransferase family; N-linked (asparagine-linked) glycosylation of proteins is mediated by a highly conserved pathway in eukaryotes, in which a lipid (dolichol phosphate)-linked oligosaccharide is assembled at the endoplasmic reticulum membrane prior to the transfer of the oligosaccharide moiety to the target asparagine residues. This oligosaccharide is composed of Glc(3)Man(9)GlcNAc(2). The addition of the three glucose residues is the final series of steps in the synthesis of the oligosaccharide precursor. Alg6 transfers the first glucose residue, and Alg8 transfers the second one. In the human alg6 gene, a C->T transition, which causes Ala333 to be replaced with Val, has been identified as the cause of a congenital disorder of glycosylation, designated as type Ic OMIM:603147.


Pssm-ID: 460831  Cd Length: 477  Bit Score: 589.08  E-value: 0e+00
                          10        20        30        40        50        60        70        80
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 56121818    21 VTLLKCLLIPTYHSTDFEVHRNWLAITHSLPISQWYYEATSEWTLDYPPFFAWFEYILSHVAKYF-DQEMLNVH-NLNYS 98
Cdd:pfam03155   1 ALLLKLLLPPMYHSTDFEVHRHWLEITHNLPISQWYFEDLSYWTLDYPPLFAYFEWLLGQIAPSFiDPEWVALHsSRGYE 80
                          90       100       110       120       130       140       150       160
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 56121818    99 SSRTLLFQRFSVIFMDVLFVY-AVRECCKCIDGKKVGKelteKPKFILSVLLLWNFGLLIVDHIHFQYNGFLFGLMLLSI 177
Cdd:pfam03155  81 SWSTKLFMRLTVIVSDLLLYIpALLLFIRKSLSGKSSK----RQQFIAALLILLSPGLLLIDHGHFQYNGFLLGLLLLSI 156
                         170       180       190       200       210       220       230       240
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 56121818   178 ARLFQKRHMEGAFLFAVLLHFKHIYLYVAPAYGVYLLRSYCFTAnkpdgsiRWKSFSFVRVISLGLVVFLVSALSLGPFL 257
Cdd:pfam03155 157 AALLKGRYLLGAILFALLLNFKHMYLYYAPAYFVYLLRKYCLNF-------PIRKFNFLRLLKLGLTVLATFALSFGPFL 229
                         250       260       270       280       290       300       310       320
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 56121818   258 ALNQLPQVFSRLFPFKRGLCHAYWAPNFWALYNALDKVLSVIGLKLKFLDpnnipkasmTSGLVQQFQHTVLPSVTPLAT 337
Cdd:pfam03155 230 YSGQLPQVLSRLFPFSRGLFHDYWAPNFWCLYNFLDKVLIVLAPRLGLLV---------TRGLVGDTSFAVLPQILPKLT 300
                         330       340       350       360       370       380       390       400
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 56121818   338 LICTLIAILPSIFCLWFKPQgPRGFLRCLTLCALSSFMFGWHVHEKAILLAILPMSLLSVGKAGDASIFLILTTTGHYSL 417
Cdd:pfam03155 301 LILTLLAQLPSLIKLFLRPS-KRLFLLALTLCSLSFFLFSWHVHEKAILLVLLPLSLLALEDPRDLSLFRWLSNVGTFSL 379
                         410       420       430       440       450       460       470       480
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 56121818   418 FPLLFTAPELPIKILLMLLFTIYSISSLKTLFRKEKP-----LFNWMETFYLLGLGPLEVCCEFVFPFTSWKVKYPFIPL 492
Cdd:pfam03155 380 FPLLFKDGLLLIKVVLTLLWNILFGLALRKLARLPFPslrvfLLDRLELLYLLSLIGMLVLHCLLHLLVPPPARYPFLPL 459
                         490
                  ....*....|....*...
gi 56121818   493 LLTSVYCAVGITYAWFKL 510
Cdd:pfam03155 460 MLTSVYCSFGVFYSFLLY 477
 
Name Accession Description Interval E-value
Alg6_Alg8 pfam03155
ALG6, ALG8 glycosyltransferase family; N-linked (asparagine-linked) glycosylation of proteins ...
21-510 0e+00

ALG6, ALG8 glycosyltransferase family; N-linked (asparagine-linked) glycosylation of proteins is mediated by a highly conserved pathway in eukaryotes, in which a lipid (dolichol phosphate)-linked oligosaccharide is assembled at the endoplasmic reticulum membrane prior to the transfer of the oligosaccharide moiety to the target asparagine residues. This oligosaccharide is composed of Glc(3)Man(9)GlcNAc(2). The addition of the three glucose residues is the final series of steps in the synthesis of the oligosaccharide precursor. Alg6 transfers the first glucose residue, and Alg8 transfers the second one. In the human alg6 gene, a C->T transition, which causes Ala333 to be replaced with Val, has been identified as the cause of a congenital disorder of glycosylation, designated as type Ic OMIM:603147.


Pssm-ID: 460831  Cd Length: 477  Bit Score: 589.08  E-value: 0e+00
                          10        20        30        40        50        60        70        80
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 56121818    21 VTLLKCLLIPTYHSTDFEVHRNWLAITHSLPISQWYYEATSEWTLDYPPFFAWFEYILSHVAKYF-DQEMLNVH-NLNYS 98
Cdd:pfam03155   1 ALLLKLLLPPMYHSTDFEVHRHWLEITHNLPISQWYFEDLSYWTLDYPPLFAYFEWLLGQIAPSFiDPEWVALHsSRGYE 80
                          90       100       110       120       130       140       150       160
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 56121818    99 SSRTLLFQRFSVIFMDVLFVY-AVRECCKCIDGKKVGKelteKPKFILSVLLLWNFGLLIVDHIHFQYNGFLFGLMLLSI 177
Cdd:pfam03155  81 SWSTKLFMRLTVIVSDLLLYIpALLLFIRKSLSGKSSK----RQQFIAALLILLSPGLLLIDHGHFQYNGFLLGLLLLSI 156
                         170       180       190       200       210       220       230       240
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 56121818   178 ARLFQKRHMEGAFLFAVLLHFKHIYLYVAPAYGVYLLRSYCFTAnkpdgsiRWKSFSFVRVISLGLVVFLVSALSLGPFL 257
Cdd:pfam03155 157 AALLKGRYLLGAILFALLLNFKHMYLYYAPAYFVYLLRKYCLNF-------PIRKFNFLRLLKLGLTVLATFALSFGPFL 229
                         250       260       270       280       290       300       310       320
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 56121818   258 ALNQLPQVFSRLFPFKRGLCHAYWAPNFWALYNALDKVLSVIGLKLKFLDpnnipkasmTSGLVQQFQHTVLPSVTPLAT 337
Cdd:pfam03155 230 YSGQLPQVLSRLFPFSRGLFHDYWAPNFWCLYNFLDKVLIVLAPRLGLLV---------TRGLVGDTSFAVLPQILPKLT 300
                         330       340       350       360       370       380       390       400
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 56121818   338 LICTLIAILPSIFCLWFKPQgPRGFLRCLTLCALSSFMFGWHVHEKAILLAILPMSLLSVGKAGDASIFLILTTTGHYSL 417
Cdd:pfam03155 301 LILTLLAQLPSLIKLFLRPS-KRLFLLALTLCSLSFFLFSWHVHEKAILLVLLPLSLLALEDPRDLSLFRWLSNVGTFSL 379
                         410       420       430       440       450       460       470       480
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 56121818   418 FPLLFTAPELPIKILLMLLFTIYSISSLKTLFRKEKP-----LFNWMETFYLLGLGPLEVCCEFVFPFTSWKVKYPFIPL 492
Cdd:pfam03155 380 FPLLFKDGLLLIKVVLTLLWNILFGLALRKLARLPFPslrvfLLDRLELLYLLSLIGMLVLHCLLHLLVPPPARYPFLPL 459
                         490
                  ....*....|....*...
gi 56121818   493 LLTSVYCAVGITYAWFKL 510
Cdd:pfam03155 460 MLTSVYCSFGVFYSFLLY 477
 
Blast search parameters
Data Source: Precalculated data, version = cdd.v.3.21
Preset Options:Database: CDSEARCH/cdd   Low complexity filter: no  Composition Based Adjustment: yes   E-value threshold: 0.01

References:

  • Wang J et al. (2023), "The conserved domain database in 2023", Nucleic Acids Res.51(D)384-8.
  • Lu S et al. (2020), "The conserved domain database in 2020", Nucleic Acids Res.48(D)265-8.
  • Marchler-Bauer A et al. (2017), "CDD/SPARCLE: functional classification of proteins via subfamily domain architectures.", Nucleic Acids Res.45(D)200-3.
Help | Disclaimer | Write to the Help Desk
NCBI | NLM | NIH